The Bone Health and Osteoporosis Foundation (BHOF) observes the month of May every year as Osteoporosis Awareness & Prevention Month to shed light on the critical needs of those living with osteoporosis. Advocates emphasize the importance of enhancing education, research, and healthcare strategies to tackle this prevalent, yet frequently neglected condition. Prioritizing prevention, early diagnosis, and advanced treatments helps improve the lives of millions impacted by osteoporosis and alleviate the strain on public healthcare systems, according to GlobalData, a leading data and analytics company.
Sulayman Patel, MSci, Pharma Analyst at GlobalData, comments: “Osteoporosis stands as the most common metabolic bone disorder globally, leading to fragility fractures due to decreased bone density and structural degradation, which heighten the risk of fractures in critical areas including the spine and hips. This condition significantly impacts patients, often requiring long-term recovery and continuous care, with hip fractures particularly associated with increased mortality. Despite its serious effects, osteoporosis is often unnoticed until a fracture occurs, thus being referred to as a ‘silent disease’.”
The progression of osteoporosis generally spans several years before culminating in a fracture, which typically necessitates medical intervention. Key symptoms include back pain resulting from vertebral fractures, which can cause visible deformity and reduced mobility. Furthermore, the condition can lead to a stooped posture, or kyphosis, as vertebral fractures cause the spine to collapse and bend forward, adversely affecting an individual’s physical functionality and quality of life.
Patel adds: “Our primary market research has identified serious unmet needs in the osteoporosis disease landscape. In particular, GlobalData reports that earlier diagnosis of osteoporosis is crucial for improving patient outcomes. Earlier detection allows for timely intervention, which can significantly reduce fracture risk, enhance quality of life, and decrease healthcare costs associated with advanced disease complications such as hip fracture. By identifying the condition before severe bone loss occurs, patients can benefit from drug therapy which can slow disease progression more effectively.”
Moreover, earlier diagnosis has the potential to improve patient awareness and education about the disease, allowing more individuals to make appropriate lifestyle changes at a much earlier stage, in order to improve long-term bone mineral density and delay the advancement of osteoporosis.
Patel continues: “According to key opinion leaders interviewed by GlobalData, the prevalence and diagnosis of osteoporosis will increase in the future, partially due to aging populations worldwide. This underlines the importance of osteoporosis awareness and programs promoting prevention worldwide.”
Patel concludes: “Initiatives to raise awareness over the disease will provide invaluable knowledge, empowering individuals to make informed health and lifestyle choices to mitigate the risk of osteoporosis and fractures.”
